Published in
American Society of Clinical Oncology, JCO Precision Oncology, 7, 2023
DOI: 10.1200/po.23.00037
Links
Tools
Loss of Chromosome 3q Is a Prognostic Marker in Fusion-Negative Rhabdomyosarcoma
Journal article published in 2023 by
Carina A. Dehner 
,
Robert C. Bell ,
Yang Cao,
Kevin He ,
John S. A. Chrisinger ,
Amy E. Armstrong ,
Marielle Yohe ,
Jack Shern ,
Angela C. Hirbe
,
Robert C. Bell ,
Yang Cao,
Kevin He ,
John S. A. Chrisinger ,
Amy E. Armstrong ,
Marielle Yohe ,
Jack Shern ,
Angela C. Hirbe
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
We show that loss of chr3q is associated with worse outcomes in fusion-negative (FN)-RMS compared with fusion-positive (FP)-RMS, suggesting that this chromosomal abnormality could be a prognostic marker for (FN) RMS.